Nanobiotix is trading 5.5% down at $36.12 after no clear company-specific catalyst was identified for August 10, 2026.
- The latest identifiable company disclosure was a July 30 voting-rights and share-capital update, not a fresh earnings release or major announcement.
- Broader markets were only modestly weaker, with the Nasdaq down 0.31%, so macro sentiment does not clearly explain the decline.